PAYX: Paychex, Inc. Stock

SIC 87 – Engineering, Accounting, Research, Management, And Related Services

Valuation
Market Cap ($M) 43,778.74
Enterprise Value ($M) 42,902.44
Book Value ($M) 3,747.10
Book Value / Share 10.41
Price / Book 11.68
NCAV ($M) 609.60
NCAV / Share 1.69
Price / NCAV 71.82

Profitability (mra)
Return on Invested Capital (ROIC) 0.36
Return on Assets (ROA) 0.16
Return on Equity (ROE) 0.49

Liquidity (mrq)
Quick Ratio 1.24
Current Ratio 1.24

Balance Sheet (mrq) ($M)
Current Assets 9,886.40
Assets 13,023.90
Liabilities 9,276.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 8.45 -1.20
02-09 13G Capital International Investors 5.20
01-26 13G/A BlackRock Inc. 7.80 -9.31
01-25 13G Golisano B Thomas 10.50 -0.01

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2024  TRANSITION REPORT PURSUANT
2023-12-21 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2023  TRANSITION REPORT PURSUANT
2023-09-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023  TRANSITION REPORT PURSUANT TO
2023-07-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 339,100 1,419,825 23.88
2024-04-23 229,372 558,475 41.07
2024-04-22 274,783 881,079 31.19
2024-04-19 414,088 1,050,884 39.40

(click for more detail)

Similar Companies
MEDP – Medpace Holdings, Inc. MXCT – MaxCyte, Inc.
NRC – National Research Corporation PINC – Premier, Inc.
RCM – R1 RCM Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Paychex Inc